Intellectual Property
More Intellectual Property Articles
Healthcare | Medical Devices
Crafting IP for Medical Devices: Targeted patent strategies can help companies gain a competitive advantage
Stephen Schaefer of Fish & Richardson discusses emerging trends in patenting medical devices, the challenges and opportunities ahead at the Patent Trial and Appeal Board, or PTAB, and how a shifting patent landscape has affected the medical device industry. His remarks have been edited for...
Read MoreIntellectual Property
Third Circuit Wades Into Intersection of IP and Antitrust: First gloss on FTC v. Actavis focuses on non-monetary branded-generic deals
On June 26, 2015, the Third Circuit became the first circuit court to interpret the United States Supreme Court’s landmark decision, FTC v. Actavis, 133 S. Ct. 2223 (2013), which held that reverse cash or “pay for delay” payments from a patent holder to a generic manufacturer are...
Read MoreHealthcare | Medical Devices
Post-Grant Pushes Forward in Life Sciences: IPRs embraced as a faster and cheaper means of challenging patents
MCC: Fish was recently named the #1 most active law firm at the PTAB. Can you share with us the work you are doing generally in the post-grant area, and specifically how you are using IPRs in your patent and litigation strategies for life sciences companies? Whelan: After the America Invents Act (...
Read More
